Elected to the Board 2005
Born: 1966
Education: Stockholm School of Economics.
Background: Co-founder of Bactiguard. CEO of the Bactiguard Group since June 2015, and the periods 2005-2014 and 2015-2020. Resigned as CEO in February 2020. Chairman of the Board 2014-2015 and Board assignments in the Group since 2005. Founder and CEO of Kinchard AB and Netpharma AB.
Other assignments: Board member of Swecare AB. Chairman of the Board of SWIB Holding AB (holding company for Smartwise Sweden AB and Procella Therapeutics AB). Owner and Board member of KK Consult AB and KK Invest AB.
Shareholdings: 2,000,000 A shares via companies and 4,179,426 B shares through family, personal holdings
Elected to the Board 2019
Born: 1966
Education: BSc Business and Economics, Stockholm School of Economics.
Background: Co-founder of Bactiguard and Chairman of the Board 2005-2013. CEO of EQT.
Other assignments: Deputy Managing Partner in EQT Partners AB, EQT Partners AB, Board member Kochcompany AB and TomEnterprise AB.
Shareholdings: 2,000,000 A-shares, 4,604,182 B-shares and 1,142,436 B-shares via a capital insurance with a company, controlled by Thomas von Koch, as beneficiary
Elected to the Board 2019
Born: 1969
Education: MD, Karolinska Institutet. Board Certified Surgeon, Ph.D., Karolinska Institutet. Professor of Surgery, Karolinska Institutet.
Background: Dean Campus North, Karolinska Institutet, Senior Consultant Surgeon, Karolinska University Hospital, Research Group Leader, Karolinska Institutet. Previous board member of Radiumhemmets Forskningsfonder, the Cancer Association in Stockholm, and the Swedish Cancer Society. Member of the Board of Research at Karolinska Institutet and member of the Board of Research KI/SLL.
Other assignments: Board member of KI Cancer, StratCan and CIMED, Karolinska Institutet. Member of the Faculty Board, Karolinska Institutet.
Shareholdings: 2 600 B shares as personal holdings and 28 818 call options
Elected to the Board 2018
Born: 1962
Education: BSc Business and Economics, Stockholm School of Economics. Studies at the MBA programme at New York University, Stern School of Business.
Background: Deputy CEO and Deputy Chairman of EQT
Other assignments: Board member of Trelleborg AB and ITB-Med AB. Founder and CEO of Trill Impact AB.
Shareholdings: 3,605,150 B shares as personal holdings
Elected to the board 2022
Born: 1971
Education: Master’s degree in international economics and licentiate degree in industrial economics from Linköping University.
Background: Former CEO of Interflora and SamSari, as well as several roles within Microsoft and WM Data. Digitization as a core competence
Other assignments: Former Chairman of the Board of Affecto Plc, Nexon Asia Pacific and Iver Holding AB, as well as Board member of Aditro and Fortnox. Board member of NCAB Group, Intrum AB, Cary Group, Recover Nordic Group and Qarlbo AB, as well as advisor to EQT Partners.,
Shareholdings: 28 818 call options
Elected to the Board 2023
Education: MD, Case Western Reserve University School of Medicine.
MSc, Biostatistics from the Harvard T.H. Chan School of Public Health.